Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernanda P Pons-Faudoa

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Biomedical Microdevices|May 20, 2019
Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseasesFernanda P Pons-Faudoa, Andrea Ballerini, Jason Sakamoto, et al.
Cureus|November 15, 2024
Extended Trochanteric Osteotomy as a Tool in the Revision of Hip Arthroplasty Due to Aseptic LooseningRené Gutiérrez-Jiménez, Felipe Delgado-Cantú, Carlos E González Rivera, et al.
Advanced Therapeutics|July 11, 2022
Extending drug release from implants via transcutaneous refilling with solid therapeuticsNicola Di Trani, Fernanda P Pons-Faudoa, Antons Sizovs, et al.
International Journal of Pharmaceutics|July 15, 2020
Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applicationsAntons Sizovs, Fernanda P Pons-Faudoa, Gulsah Malgir, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 29, 2019
2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxisFernanda P Pons-Faudoa, Antons Sizovs, Nicola Di Trani, et al.
Journal of Cancer Survivorship : Research and Practice|April 23, 2026
Five-year longitudinal changes in social, economic, and psychosocial wellbeing among young women with breast cancer in MexicoCynthia Villarreal-Garza, Fernanda P Pons-Faudoa, Alejandra Platas, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 22, 2025
Localized inflammasome inhibition mitigates foreign body response to subcutaneous long-acting antiretroviral therapy for HIVIlaria Facchi, Nicola Di Trani, Camden Caffey, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 2023
Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaquesFernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 29, 2023
Changes in local tissue microenvironment in response to subcutaneous long-acting delivery of tenofovir alafenamide in rats and non-human primatesFernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.
Pharmaceutics|October 21, 2020
Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic ImplantFernanda P Pons-Faudoa, Nicola Di Trani, Antons Sizovs, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biomedical Microdevices|May 20, 2019
Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseasesFernanda P Pons-Faudoa, Andrea Ballerini, Jason Sakamoto, et al.
Cureus|November 15, 2024
Extended Trochanteric Osteotomy as a Tool in the Revision of Hip Arthroplasty Due to Aseptic LooseningRené Gutiérrez-Jiménez, Felipe Delgado-Cantú, Carlos E González Rivera, et al.
Advanced Therapeutics|July 11, 2022
Extending drug release from implants via transcutaneous refilling with solid therapeuticsNicola Di Trani, Fernanda P Pons-Faudoa, Antons Sizovs, et al.
International Journal of Pharmaceutics|July 15, 2020
Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applicationsAntons Sizovs, Fernanda P Pons-Faudoa, Gulsah Malgir, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 29, 2019
2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxisFernanda P Pons-Faudoa, Antons Sizovs, Nicola Di Trani, et al.
Journal of Cancer Survivorship : Research and Practice|April 23, 2026
Five-year longitudinal changes in social, economic, and psychosocial wellbeing among young women with breast cancer in MexicoCynthia Villarreal-Garza, Fernanda P Pons-Faudoa, Alejandra Platas, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 22, 2025
Localized inflammasome inhibition mitigates foreign body response to subcutaneous long-acting antiretroviral therapy for HIVIlaria Facchi, Nicola Di Trani, Camden Caffey, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 2023
Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaquesFernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 29, 2023
Changes in local tissue microenvironment in response to subcutaneous long-acting delivery of tenofovir alafenamide in rats and non-human primatesFernanda P Pons-Faudoa, Nicola Di Trani, Simone Capuani, et al.
Pharmaceutics|October 21, 2020
Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic ImplantFernanda P Pons-Faudoa, Nicola Di Trani, Antons Sizovs, et al.
Pageof 2